These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3140056)

  • 1. Acquisition, development, and treatment of Panamanian cutaneous leishmaniasis: a case history.
    Chaniotis BN; Johnson CM; Christensen HA; de Vasquez AM
    Mil Med; 1988 Aug; 153(8):405-6. PubMed ID: 3140056
    [No Abstract]   [Full Text] [Related]  

  • 2. Antileishmanial activity of antimonials entrapped in liposomes.
    New RR; Chance ML; Thomas SC; Peters W
    Nature; 1978 Mar; 272(5648):55-6. PubMed ID: 203863
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of topical tartar emetic in cutaneous leishmaniasis].
    Romero GA; Vela JS; Marsden PD
    Rev Soc Bras Med Trop; 1996; 29(4):377. PubMed ID: 8768589
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical therapy of cutaneous leishmaniasis with 2% ketoconazole ointment and DMSO.
    Dutz W; Agarval N; Bashardost MZ; Bentley G; Kindmark CO
    Int J Dermatol; 1987 Apr; 26(3):199. PubMed ID: 3570599
    [No Abstract]   [Full Text] [Related]  

  • 5. Leishmaniasis in the United States. A report of ten cases in military personnel.
    Kern F; Pedersen JK
    JAMA; 1973 Nov; 226(8):872-4. PubMed ID: 4800334
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of late cutaneous leishmaniasis by simultaneous intralesional steroid and intramuscular antimony.
    Dostrovsky A; Cohen HA
    Dermatol Int; 1967; 6(3):172-3. PubMed ID: 5590122
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro additive interaction between ketoconazole and antimony against intramacrophage Leishmania (Leishmania) amazonensis amastigotes.
    Nunes DCO; Bispo-da-Silva LB; Napolitano DR; Costa MS; Figueira MMNR; Rodrigues RS; Rodrigues VM; Yoneyama KAG
    PLoS One; 2017; 12(6):e0180530. PubMed ID: 28662149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of American dermal leishmaniasis with a special oral dosage form of tartar emetic.
    HOEKENGA MT; TUCKER HA
    Am J Trop Med Hyg; 1959 May; 8(3):342-5. PubMed ID: 13661535
    [No Abstract]   [Full Text] [Related]  

  • 9. Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study.
    El-Sayed M; Anwar AE
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):335-40. PubMed ID: 19744259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful treatment of antimony-resistant cutaneous leishmaniasis].
    Kremsner P; Lang I; Kollaritsch H
    Hautarzt; 1987 Dec; 38(12):733-5. PubMed ID: 2830206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An unusual case: cutaneous leishmaniasis with subcutaneous nodule--successfully treated with oral ketoconazole].
    Tratner A; Ingber A; Segal B; Wiesman-Katzenelson W; Sandbank M
    Z Hautkr; 1990 Oct; 65(10):927-8. PubMed ID: 2291292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intradermal treatment of cutaneous leishmaniasis with two antimonial drugs.
    Morsy TA; Essa MH; Aboul Anaan AM; Montasser MF
    J Egypt Soc Parasitol; 1988 Jun; 18(1):341-4. PubMed ID: 2836525
    [No Abstract]   [Full Text] [Related]  

  • 13. [What did prove useful in the treatment of leishmaniasis].
    Kurban A
    Hautarzt; 1973 Jun; 24(6):271. PubMed ID: 4723879
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimony plus recombinant human granulocyte-macrophage colony-stimulating factor applied topically in low doses enhances healing of cutaneous Leishmaniasis ulcers: a randomized, double-blind, placebo-controlled study.
    Santos JB; de Jesus AR; Machado PR; Magalhães A; Salgado K; Carvalho EM; Almeida RP
    J Infect Dis; 2004 Nov; 190(10):1793-6. PubMed ID: 15499535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent cutaneous leishmaniasis: successful treatment with sodium antimony gluconate.
    Aram H; el-On J
    Cutis; 1986 Mar; 37(3):177-9. PubMed ID: 3007035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral pentoxifylline and pentavalent antimony for treatment of leishmaniasis: promising but inconclusive evidence of superiority, compared with antimony monotherapy.
    Ojha RP; Cervantes D; Fischbach LA
    Clin Infect Dis; 2007 Oct; 45(8):1104; author reply 1005-6. PubMed ID: 17879933
    [No Abstract]   [Full Text] [Related]  

  • 17. Response to ketoconazole in two cases of longstanding cutaneous leishmaniasis.
    Viallet J; MacLean JD; Robson H
    Am J Trop Med Hyg; 1986 May; 35(3):491-5. PubMed ID: 3706620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of topical ketoconazole in cutaneous leishmaniasis.
    Abahusein A; Larbi EB; al-Khawajah A; al-Gindan Y; Jain S
    East Afr Med J; 1992 Jan; 69(1):14-7. PubMed ID: 1628541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure to cure Leishmania braziliensis guyanensis cutaneous leishmaniasis with oral ketoconazole.
    Dedet JP; Jamet P; Esterre P; Ghipponi PM; Genin C; Lalande G
    Trans R Soc Trop Med Hyg; 1986; 80(1):176. PubMed ID: 3726992
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative toxicity and tissue distribution of antimony potassium tartrate in rats and mice dosed by drinking water or intraperitoneal injection.
    Dieter MP; Jameson CW; Elwell MR; Lodge JW; Hejtmancik M; Grumbein SL; Ryan M; Peters AC
    J Toxicol Environ Health; 1991 Sep; 34(1):51-82. PubMed ID: 1890693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.